Screener / SEC EDGAR /CIK 0001428336 /10-K filed Mar 17, 2026, compared with Mar 18, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Industrials · Business Services

Healthequity, Inc. HQY

Compare with peers Embed
What it said it expected, against what it reported

7 targets with a reported result

Releases of the last 3 years
Above the range 7 above the last range given
Within the range 0 of 7 range targets
Below the range 0 below the last range given

The numbers HQY said it expected, in its earnings releases, next to what it then reported for the same period.

Target by target

Each target, with the sentence it came from · release and 10-Q or 10-K

The last range givenReported, abovewithin or keptbelow or missed
TargetWhat the company saidReportedResult
EBITDA (company-defined)
Fiscal 2027
Given $618.00M to $628.00M release Mar 17, 2026
Raised $625.00M to $633.00M release May 28, 2026
Raised $628.00M to $636.00M release Aug 27, 2026
– No standard number
The company's words
Outlook for the year ending (in millions) January 31, 2027 … Adjusted EBITDA $618 - 628 release Mar 17, 2026
Outlook for the year ending (in millions) January 31, 2027 … Adjusted EBITDA $625 - 633 release May 28, 2026
Outlook for the year ending (in millions) January 31, 2027 … Adjusted EBITDA $628 - 636 release Aug 27, 2026
Net income
Fiscal 2027
Given $239.00M to $246.00M release Mar 17, 2026
Raised $242.00M to $248.00M release May 28, 2026
Kept $242.00M to $248.00M release Aug 27, 2026
– Not reported yet
The company's words
Outlook for the year ending (in millions) January 31, 2027 … Net income $239 - 246 release Mar 17, 2026
Outlook for the year ending (in millions) January 31, 2027 … Net income $242 - 248 release May 28, 2026
Outlook for the year ending (in millions) January 31, 2027 … Net income $242 - 248 release Aug 27, 2026
Net income (company-defined)
Fiscal 2027
Given $392.00M to $400.00M release Mar 17, 2026
Lowered $392.00M to $398.00M release May 28, 2026
Kept $392.00M to $398.00M release Aug 27, 2026
– No standard number
The company's words
Outlook for the year ending (in millions, except per share data) January 31, 2027 … Non-GAAP net income $392 - 400 release Mar 17, 2026
Outlook for the year ending (in millions, except per share data) January 31, 2027 … Non-GAAP net income $392 - 398 release May 28, 2026
Outlook for the year ending (in millions, except per share data) January 31, 2027 … Non-GAAP net income $392 - 398 release Aug 27, 2026
Diluted EPS
Fiscal 2027
Given $2.78 to $2.85 release Mar 17, 2026
Raised $2.88 to $2.95 release May 28, 2026
Raised $2.88 to $2.96 release Aug 27, 2026
– Not reported yet
The company's words
Outlook for the year ending (in millions, except per share data) January 31, 2027 … GAAP net income per diluted share (2) $2.78 - 2.85 release Mar 17, 2026
Outlook for the year ending (in millions, except per share data) January 31, 2027 … GAAP net income per diluted share $2.88 - 2.95 release May 28, 2026
Outlook for the year ending (in millions, except per share data) January 31, 2027 … GAAP net income per diluted share $2.88 - 2.96 release Aug 27, 2026
Diluted EPS (company-defined)
Fiscal 2027
Given $4.56 to $4.65 release Mar 17, 2026
Raised $4.66 to $4.73 release May 28, 2026
Kept $4.66 to $4.73 release Aug 27, 2026
– No standard number
The company's words
Outlook for the year ending (in millions, except per share data) January 31, 2027 … Non-GAAP net income per diluted share (2) $4.56 - 4.65 release Mar 17, 2026
Outlook for the year ending (in millions, except per share data) January 31, 2027 … Non-GAAP net income per diluted share $4.66 - 4.73 release May 28, 2026
Outlook for the year ending (in millions, except per share data) January 31, 2027 … Non-GAAP net income per diluted share $4.66 - 4.73 release Aug 27, 2026
Revenue
Fiscal 2027
Given $1.41B to $1.42B release Mar 17, 2026
Raised $1.41B to $1.42B release May 28, 2026
Kept $1.41B to $1.42B release Aug 27, 2026
– Not reported yet
The company's words
For the fiscal year ending January 31, 2027, management expects revenues of $1.405 billion to $1.415 billion. release Mar 17, 2026
For the fiscal year ending January 31, 2027, management expects revenues of $1.410 billion to $1.420 billion. release May 28, 2026
For the fiscal year ending January 31, 2027, management is raising guidance and now expects revenues of $1.411 billion to $1.421 billion. release Aug 27, 2026
EBITDA (company-defined)
Fiscal 2026 (ended Jan 31, 2026)
Given $525.00M to $545.00M release Mar 18, 2025
Raised $530.00M to $550.00M release Jun 3, 2025
Raised $540.00M to $560.00M release Sep 2, 2025
Raised $555.00M to $565.00M release Dec 3, 2025
– No standard number
The company's words
Outlook for the year ending (in millions) January 31, 2026 … Adjusted EBITDA $525 - 545 release Mar 18, 2025
Outlook for the year ending (in millions) January 31, 2026 … Adjusted EBITDA $530 - 550 release Jun 3, 2025
Outlook for the year ending (in millions) January 31, 2026 … Adjusted EBITDA $540 - 560 release Sep 2, 2025
Outlook for the year ending (in millions) January 31, 2026 … Adjusted EBITDA $555 - 565 release Dec 3, 2025
Net income
Fiscal 2026 (ended Jan 31, 2026)
Given $164.00M to $179.00M release Mar 18, 2025
Raised $173.00M to $188.00M release Jun 3, 2025
Raised $185.00M to $200.00M release Sep 2, 2025
Raised $197.00M to $205.00M release Dec 3, 2025
$215.20M
10-K filed 2026-03-17
Above the range
The company's words
Outlook for the year ending (in millions) January 31, 2026 … Net income $164 - 179 release Mar 18, 2025
Outlook for the year ending (in millions) January 31, 2026 … Net income $173 - 188 release Jun 3, 2025
Outlook for the year ending (in millions) January 31, 2026 … Net income $185 - 200 release Sep 2, 2025
Outlook for the year ending (in millions) January 31, 2026 … Net income $197 - 205 release Dec 3, 2025
Net income (company-defined)
Fiscal 2026 (ended Jan 31, 2026)
Given $318.00M to $333.00M release Mar 18, 2025
Raised $320.00M to $335.00M release Jun 3, 2025
Raised $329.00M to $344.00M release Sep 2, 2025
Raised $341.00M to $348.00M release Dec 3, 2025
– No standard number
The company's words
Outlook for the year ending (in millions, except per share data) January 31, 2026 … Non-GAAP net income $318 - 333 release Mar 18, 2025
Outlook for the year ending (in millions, except per share data) January 31, 2026 … Non-GAAP net income $320 - 335 release Jun 3, 2025
Outlook for the year ending (in millions, except per share data) January 31, 2026 … Non-GAAP net income $329 - 344 release Sep 2, 2025
Outlook for the year ending (in millions, except per share data) January 31, 2026 … Non-GAAP net income $341 - 348 release Dec 3, 2025
Diluted EPS
Fiscal 2026 (ended Jan 31, 2026)
Given $1.85 to $2.01 release Mar 18, 2025
Raised $1.96 to $2.13 release Jun 3, 2025
Raised $2.11 to $2.28 release Sep 2, 2025
Raised $2.24 to $2.33 release Dec 3, 2025
$2.46
10-K filed 2026-03-17
Above the range
The company's words
Outlook for the year ending (in millions, except per share data) January 31, 2026 … GAAP net income per diluted share (2) $1.85 - 2.01 release Mar 18, 2025
Outlook for the year ending (in millions, except per share data) January 31, 2026 … GAAP net income per diluted share (2) $1.96 - 2.13 release Jun 3, 2025
Outlook for the year ending (in millions, except per share data) January 31, 2026 … GAAP net income per diluted share (2) $2.11 - 2.28 release Sep 2, 2025
Outlook for the year ending (in millions, except per share data) January 31, 2026 … GAAP net income per diluted share (2) $2.24 - 2.33 release Dec 3, 2025
Diluted EPS (company-defined)
Fiscal 2026 (ended Jan 31, 2026)
Given $3.57 to $3.74 release Mar 18, 2025
Raised $3.61 to $3.78 release Jun 3, 2025
Raised $3.74 to $3.91 release Sep 2, 2025
Raised $3.87 to $3.95 release Dec 3, 2025
– No standard number
The company's words
Outlook for the year ending (in millions, except per share data) January 31, 2026 … Non-GAAP net income per diluted share (2) $3.57 - 3.74 release Mar 18, 2025
Outlook for the year ending (in millions, except per share data) January 31, 2026 … Non-GAAP net income per diluted share (2) $3.61 - 3.78 release Jun 3, 2025
Outlook for the year ending (in millions, except per share data) January 31, 2026 … Non-GAAP net income per diluted share (2) $3.74 - 3.91 release Sep 2, 2025
Outlook for the year ending (in millions, except per share data) January 31, 2026 … Non-GAAP net income per diluted share (2) $3.87 - 3.95 release Dec 3, 2025
Revenue
Fiscal 2026 (ended Jan 31, 2026)
Given $1.27B to $1.29B release Dec 9, 2024
Raised $1.28B to $1.30B release Mar 18, 2025
Raised $1.28B to $1.30B release Jun 3, 2025
Raised $1.29B to $1.31B release Sep 2, 2025
Raised $1.30B to $1.31B release Dec 3, 2025
$1.31B
10-K filed 2026-03-17
Above the range
The company's words
For the fiscal year ending January 31, 2026, management expects revenue of approximately $1.275 billion to $1.295 billion and Adjusted EBITDA of approximately 41.5% to 42.5% of revenue. release Dec 9, 2024
For the fiscal year ending January 31, 2026, management expects revenues of $1.280 billion to $1.305 billion. release Mar 18, 2025
For the fiscal year ending January 31, 2026, management expects revenues of $1.285 billion to $1.305 billion. release Jun 3, 2025
For the fiscal year ending January 31, 2026, management expects revenues of $1.290 billion to $1.310 billion. release Sep 2, 2025
For the fiscal year ending January 31, 2026, management expects revenues of $1.302 billion to $1.312 billion. release Dec 3, 2025
EBITDA (company-defined)
Fiscal 2025 (ended Jan 31, 2025)
Given $438.00M to $458.00M release Mar 19, 2024
Raised $454.00M to $474.00M release Jun 3, 2024
Raised $458.00M to $478.00M release Sep 3, 2024
Raised $470.00M to $480.00M release Dec 9, 2024
– No standard number
The company's words
Outlook for the year ending (in millions) January 31, 2025 … Adjusted EBITDA $438 - 458 release Mar 19, 2024
Outlook for the year ending (in millions) January 31, 2025 … Adjusted EBITDA $454 - 474 release Jun 3, 2024
Outlook for the year ending (in millions) January 31, 2025 … Adjusted EBITDA $458 - 478 release Sep 3, 2024
Outlook for the year ending (in millions) January 31, 2025 … Adjusted EBITDA $470 - 480 release Dec 9, 2024
Net income
Fiscal 2025 (ended Jan 31, 2025)
Given $73.00M to $88.00M release Mar 19, 2024
Raised $90.00M to $105.00M release Jun 3, 2024
Raised $94.00M to $109.00M release Sep 3, 2024
Lowered $88.00M to $96.00M release Dec 9, 2024
$96.70M
10-K filed 2025-03-18
Above the range
The company's words
Outlook for the year ending (in millions) January 31, 2025 … Net income $73 - 88 release Mar 19, 2024
Outlook for the year ending (in millions) January 31, 2025 … Net income $90 - 105 release Jun 3, 2024
Outlook for the year ending (in millions) January 31, 2025 … Net income $94 - 109 release Sep 3, 2024
Outlook for the year ending (in millions) January 31, 2025 … Net income $88 - 96 release Dec 9, 2024
Net income (company-defined)
Fiscal 2025 (ended Jan 31, 2025)
Given $247.00M to $262.00M release Mar 19, 2024
Raised $261.00M to $276.00M release Jun 3, 2024
Raised $265.00M to $280.00M release Sep 3, 2024
Raised $274.00M to $281.00M release Dec 9, 2024
– No standard number
The company's words
Outlook for the year ending (in millions, except per share data) January 31, 2025 … Non-GAAP net income $247 - 262 release Mar 19, 2024
Outlook for the year ending (in millions, except per share data) January 31, 2025 … Non-GAAP net income $261 - 276 release Jun 3, 2024
Outlook for the year ending (in millions, except per share data) January 31, 2025 … Non-GAAP net income $265 - 280 release Sep 3, 2024
Outlook for the year ending (in millions, except per share data) January 31, 2025 … Non-GAAP net income $274 - 281 release Dec 9, 2024
Diluted EPS
Fiscal 2025 (ended Jan 31, 2025)
Given $0.83 to $0.99 release Mar 19, 2024
Raised $1.01 to $1.18 release Jun 3, 2024
Raised $1.05 to $1.22 release Sep 3, 2024
Lowered $0.99 to $1.08 release Dec 9, 2024
$1.09
10-K filed 2025-03-18
Above the range
The company's words
Outlook for the year ending (in millions, except per share data) January 31, 2025 … GAAP net income per diluted share (2) $0.83 - 0.99 release Mar 19, 2024
Outlook for the year ending (in millions, except per share data) January 31, 2025 … GAAP net income per diluted share (2) $1.01 - 1.18 release Jun 3, 2024
Outlook for the year ending (in millions, except per share data) January 31, 2025 … GAAP net income per diluted share (2) $1.05 - 1.22 release Sep 3, 2024
Outlook for the year ending (in millions, except per share data) January 31, 2025 … GAAP net income per diluted share (2) $0.99 - 1.08 release Dec 9, 2024
Diluted EPS (company-defined)
Fiscal 2025 (ended Jan 31, 2025)
Given $2.79 to $2.96 release Mar 19, 2024
Raised $2.93 to $3.10 release Jun 3, 2024
Raised $2.98 to $3.14 release Sep 3, 2024
Raised $3.08 to $3.16 release Dec 9, 2024
– No standard number
The company's words
Outlook for the year ending (in millions, except per share data) January 31, 2025 … Non-GAAP net income per diluted share (2) $2.79 - 2.96 release Mar 19, 2024
Outlook for the year ending (in millions, except per share data) January 31, 2025 … Non-GAAP net income per diluted share (2) $2.93 - 3.10 release Jun 3, 2024
Outlook for the year ending (in millions, except per share data) January 31, 2025 … Non-GAAP net income per diluted share (2) $2.98 - 3.14 release Sep 3, 2024
Outlook for the year ending (in millions, except per share data) January 31, 2025 … Non-GAAP net income per diluted share (2) $3.08 - 3.16 release Dec 9, 2024
Revenue
Fiscal 2025 (ended Jan 31, 2025)
Given $1.14B to $1.16B release Dec 5, 2023
Kept $1.14B to $1.16B release Feb 21, 2024
Kept $1.14B to $1.16B release Mar 19, 2024
Raised $1.16B to $1.18B release Jun 3, 2024
Raised $1.17B to $1.19B release Sep 3, 2024
Raised $1.19B to $1.20B release Dec 9, 2024
$1.20B
10-K filed 2025-03-18
Above the range
The company's words
For the fiscal year ending January 31, 2025, management expects revenue of approximately $1.140 billion to $1.160 billion and Adjusted EBITDA of approximately 38-39% of revenue. release Dec 5, 2023
For the fiscal year ending January 31, 2025, the Company affirmed its previously provided outlook, which assumes an average annualized yield on HSA cash of approximately 3%, as follows: … Revenue in the range of $1.140 billion to $1.160 billion; release Feb 21, 2024
For the fiscal year ending January 31, 2025, management expects revenues of $1.14 billion to $1.16 billion. release Mar 19, 2024
For the fiscal year ending January 31, 2025, management expects revenue of $1.16 billion to $1.18 billion. release Jun 3, 2024
For the fiscal year ending January 31, 2025, management expects revenue of $1.165 billion to $1.185 billion. release Sep 3, 2024
For the fiscal year ending January 31, 2025, management expects revenue of $1.185 billion to $1.195 billion. release Dec 9, 2024
EBITDA (company-defined)
Fiscal 2024 (ended Jan 31, 2024)
Given $350.00M to $360.00M release Dec 5, 2023
– No standard number
The company's words
Outlook for the year ending (in millions) January 31, 2024 … Adjusted EBITDA $350 - 360 release Dec 5, 2023
Net income (company-defined)
Fiscal 2024 (ended Jan 31, 2024)
Given $181.00M to $188.00M release Dec 5, 2023
– No standard number
The company's words
Outlook for the year ending (in millions, except per share data) January 31, 2024 … Non-GAAP net income $181 - 188 release Dec 5, 2023
Diluted EPS (company-defined)
Fiscal 2024 (ended Jan 31, 2024)
Given $2.08 to $2.16 release Dec 5, 2023
– No standard number
The company's words
Outlook for the year ending (in millions, except per share data) January 31, 2024 … Non-GAAP net income per diluted share (2) $2.08 - 2.16 release Dec 5, 2023
Revenue
Fiscal 2024 (ended Jan 31, 2024)
Given $985.00M to $995.00M release Dec 5, 2023
$999.59M
10-K filed 2024-03-22
Above the range
The company's words
For the fiscal year ending January 31, 2024, management expects revenue of $985 million to $995 million. release Dec 5, 2023
1 target far from the company's reported total, so not compared (usually a target for one product, segment or definition)
  • Net income, Fiscal 2024 (ended Jan 31, 2024): said $34.00M to $39.00M, reported $55.71M. The company's words

Targets are read from the sentences of the EX-99 exhibits of 8-K item 2.02 filings (15 releases since 2023-12-05), without AI; in outlook tables only the first column is read. The result compares the reported number with the last range given before the period was reported. Results come from SEC's XBRL company facts, as first reported. A company's target can use its own definition (META's capital expenditures include finance lease payments, for example), so read the quote.

Sources

The outlook sentences of each earnings release (8-K item 2.02, exhibit 99), read without AI; results from SEC's XBRL company facts, as first reported.

Also

Earnings releases: each release in full.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/HQY/export.csv") into a cell.

Next:Archive
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.